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CD4CD3 Accessory Cells Costimulate
Primed CD4 T Cells through OX40 and CD30
at Sites Where T Cells Collaborate with B Cells
and is almost certainly provided by professional antigen-
presenting dendritic cells (DCs) during priming. CD28-
activated CD4 cells upregulate OX40 (Walker et al.,
1999), which is not expressed on naive cells (Mallett et
al., 1990), permitting secondary signals from OX40 li-
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Medical Research Council Centre for Immune gand expressed on CD40-activated DCs (Brocker et al.,
1999; Ohshima et al., 1997). In vitro, OX40 signals canRegulation
University of Birmingham Medical School promote Th2 development (Baum et al., 1994; Flynn et
al., 1998; Ohshima et al., 1998), and OX40 signals toVincent Drive
Birmingham B15 2TT CD4 T cells in vitro (Flynn et al., 1998) and in vivo (Brocker
et al., 1999) upregulate expression of the chemokineUnited Kingdom
receptor CXCR-5, which directs their migration to B folli-
cles (Forster et al., 1996) where the ligand is expressed
(Gunn et al., 1998). CXCR-5 CD4 T cells are associatedSummary
with help for GC development (Breitfeld et al., 2000;
Campbell et al., 2001; Kim et al., 2001), so it is plausibleIn this report we identify an accessory cell that inter-
acts with primed and memory T cells at sites where that sequential signals from DCs through CD28 and then
OX40 are components of the signaling pathway thatthey collaborate with B cells. These cells are distin-
guished from conventional dendritic cells by their lack directs T cells to migrate to and interact with B cells.
Since conventional DCs are restricted to the T zone, itof response to Flt3 ligand and their inability to process
antigen. Unlike dendritic cells, the CD4CD3 cells seemed possible that other cell types at the B:T interface
and in B follicles might mediate B:T interactions. In thishave little CD80 or CD86 expression but do express
high levels of the TNF ligands, OX40 ligand and CD30 report we have characterized such an accessory cell
that is phenotypically and functionally distinct from DCs.ligand. We show that Th2-primed cells express the
receptors for these TNF ligands and preferentially sur- We provide evidence that suggests that these cells are
the adult equivalent of CD4CD3 cells found to colo-vive when cocultured with these cells. Furthermore,
we show that the preferential survival of OX40 T cells nize fetal secondary lymphoid organs early in ontogeny
(Mebius et al., 1997). We show that these cells are inti-and support of memory T cell help for B cells are linked
to their association with CD4CD3 cells in vivo. mately associated with antigen-specific T cells during
primary and memory phases of immune responses to
Th2 antigens and find that the survival of OX40 memoryIntroduction
CD4 T cells providing help for secondary B cell re-
sponses is linked to OX40 ligand signals provided byThe generation of antibody responses to protein anti-
gens requires the rapid expansion of generally rare anti- these cells.
gen-specific CD4 T cells and their recruitment to the
two principle sites where they collaborate with B cells. Results
In the T zone they provide help for B cells, enabling
the rapid generation of primary nonsomatically mutated Identification of a Subset of CD4CD3
plasma cells in extrafollicular foci (Jacob et al., 1991; Cells in B Follicles
Liu et al., 1991). In B follicles CD4 T cells initiate the We first set out to determine whether there were conven-
development of germinal centers (GCs), which subse- tional CD11cDCs in B cell areas using confocal micros-
quently give rise to the precursors of long-lived plasma copy of mouse spleen tissue sections (see Figures 1A
cells (Ho et al., 1986; Slifka et al., 1998). Furthermore, and 1B). This showed that the majority of CD11c DCs
following reexposure to antigen, primed memory CD4 were located in and around the T zone or in the red
T cells provide help to both memory and naive B cells pulp, with CD11c cells being rare in B follicles (Figure
for accelerated secondary immune responses. 1A). However, there were many CD4 cells in B follicles
The cellular and molecular interactions that direct that were CD11c, and most of these CD4 follicular
T cells to help B cells during priming and to survive to cells were not T cells as they lacked CD3 (Figure 1A).
provide help in secondary responses are still incom- The presence of CD4CD3 cells in B cell areas did not
pletely understood. In vitro differentiated Th2 CD4 cells require GCs, as mice lacking CD40 or CD28 signaling
are more effective inducers of GCs than Th1 cells (Ran- had normal numbers of CD4CD3 cells (data not
dolph et al., 1999; Secord et al., 1996), and this is associ- shown).
ated with their preferential migration to the B:T interface,
a major site of B:T collaboration (Randolph et al., 1999). Image Processing of Confocal Images to Identify
The CD28 costimulatory signal to T cells is essential for Positively the Location of CD4CD3 Cells
GC development (Ferguson et al., 1996; Lane et al., 1994) in Relation to CD11c DC Subsets
Because it was hard to identify CD4CD3CD11c cells
unequivocally in areas where there were significant*Correspondence: p.j.l.lane@bham.ac.uk
1These authors contributed equally to this work. numbers of CD4 T cells, we resorted to image pro-
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cessing of confocal images (see Experimental Proce- The associations of antigen-specific T cells with DCs
and CD4CD3 cells in confocal images that scan adures). Serial sections were stained to identify CD11c
DCs and IgM B cells. To identify the relative locations 2.6 M slice through the tissue when viewed with 63
objective were enumerated. As only part of each OTIIof the respective CD4CD3CD11c cells and CD11c
DC populations, the CD4CD11cCD3 digital image CD4 T cell membrane is analyzed, this underestimates
the true association percentage. Nevertheless, on daywas merged with the CD11c digital image. The IgM
digital matrix from the two images was used to align B 2 after transfer 50/56 (89%) of transferred CD4 T cells
are found associated with DCs but only 5/38 (13%) withfollicle areas, and then the individual overlapping matri-
ces were assigned pseudocolors to identify IgM (gray), CD4CD3 cells. By day 5 at the peak of the OTII CD4
T cell expansion (data not shown), this pattern hadCD4CD3CD11c (red), CD11c (green).
The resulting image (Figure 1B) shows clearly the rela- changed. While 79/115 (69%) OTII CD4 cells still had
contacts with DCs, 74/110 (67%) were now found asso-tive location of CD4CD3 cells. In addition to being
found in B cell areas, these cells are found at the B:T ciated with CD4CD3 cells, consistent with the idea
that primed CD4 T cells migrate to and associate withinterface, in the marginal sinus, and a few cells occur
in the central T zone. In contrast, virtually all CD11c CD4CD3 cells after priming on DCs.
DCs are found in either the T zone or in the red pulp.
Purification and Immunophenotype of CD4CD3
Cells versus CD11c DCsCD4 T Cells Contact Cell Membranes of CD4CD3
Cells Both at the B:T Interface and in GCs CD4CD3 cells were prepared by negatively selecting
CD11c cells from spleen suspensions from Rag1-defi-To determine whether antigen-specific CD4 T cells were
in contact with CD4CD3 cells at the B:T interface, cient (Rag1) mice. CD4 cells were then isolated by
positive selection from the CD11c fraction. PurifiedCD45.1-marked transgenic OTII cells were transferred
into CD40 ligand-deficient congenic recipients which cells were incubated overnight in culture medium at
37C and immunostained the following day. Two cellwere immunized a day later with the Th2 immunogen
alum-precipitated ovalbumin (Toellner et al., 1998). Fig- populations are purified by this procedure (see Figure
2A). The first is a population that expresses CD11c andure 1C shows a low-power and the inset shows a high-
power image of a CD4CD3 cell interacting with an little CD4; this can be further subdivided by expression
of CD8 (Figures 2Ab and 2Ac). The second populationantigen-specific transferred CD4 T cell 3 days after im-
munization. What is clearly shown in this confocal image is CD4CD11clow/ (Figure 2Aa). The immunophenotype
of the CD11c DCs shown is similar to conventional(Figure 1C) is the dendritic morphology of the CD4CD3
cell and the intimate contact of membranes between it CD11c DCs (data not shown). Unlike the CD11c frac-
tion, the CD4CD3 cells express lower levels of MHCand the antigen-specific transferred T cell. Similar inter-
actions were also seen in GCs (Figure 1D). As the recipi- class II, CD40, CD80 and CD86 (Figure 2Aa). This was
independently confirmed by staining with CTLA-4Igent mice were CD40 ligand-deficient, host cells cannot
provide help for GC B cell proliferation, so there are no (data not shown). In marked contrast, CD4CD3 cells
express high levels of the TNF family members, OX40background GCs. Figure 1D and the inset show low-
and high-power images of a nascent GC showing a ligand and CD30 ligand (Figure 2Aa). This again was
independently confirmed using a murine OX40-Ig fusiontransferred antigen-specific T cell interacting with a
CD4CD3 cell, illustrating again that these cells inter- protein in addition to mAbs to murine OX40 ligand and
CD30 ligand (data not shown). Unlike CD11c DCs thatact with primed T cells at sites of T:B collaboration in
B follicles. can express modest levels of OX40 ligand but not CD30
Figure 1. Confocal Micrographs of Mouse Spleen Sections Showing the Location of CD4CD3 Cells and Interactions with Primed CD4 T
Cells
(A) Low-power (10 optic) confocal image showing IgM-stained cells (gray), CD4 (red), and CD11c and CD3 (blue). CD3CD4 T cells and
CD4CD11c DCs are stained purple. Scale bar, 50 M.
(B) Digitally processed confocal image of (A). CD11c and CD3 cells were eliminated from the image in (A) by digital processing, leaving
CD4 cells in red and IgM cells in gray (see text). The consecutive serial section, stained and processed to identify CD4/CD8CD11c cells
(green), was merged with the processed version of (A), and the IgM staining was used to align the B follicle areas. The resulting image shows
the relative locations of the CD4CD3 CD11c population (red) and the CD11c population (green) in the context of the B follicle (IgM cells
in gray). Scale bar, 50 M.
(C) Confocal image (40 optic) of CD4CD3 cell interaction with antigen-specific T cells (inside red box) at the B:T junction in an area of
splenic section from a mouse immunized 3 days previously. IgM, gray; CD4, red; CD45.1, green; CD3 and CD11c cells, blue. Transferred
antigen-specific T cells appear white (as they stain for CD45.1, CD4, and CD3). Scale bar, 20 M. (Inset) Enlargement of the area in the red
box in (C). Scale bar, 5 M.
(D) Low-power confocal image (10 optic) of CD4CD3 cell interaction with antigen-specific T cell (inside red box) in a nascent GC from a
mouse immunized 10 days previously and stained as in (C). Scale bar, 50 M. (Inset) High-power image (63 optic, enlarged area) of the area
in the red box in (D). Scale bar, 5 M.
(E) Low-power confocal image (40 optic) of CD4CD3 cell interaction (red) with OX40 T cell (green) in the outer T zone. Scale bar, 20 M.
(Inset) High-power image (63 optic, enlarged area) of the area in the red box in (E). Scale bar, 5 M.
(F) Low-power confocal image (40 optic) of a spleen section taken from a Rag1 4 weeks following transfer of 107 splenocytes from an OTII
transgenic mouse. The white squares show associations of CD4CD3 cell interactions with OX40 transgenic OTII cells. The white circles
show OX40 transgenic T cells not obviously associated. Scale bar, 20 M. (Inset) High-power image (63 optic, enlarged area) of the area
in the red box, showing an association between a CD4CD3 cell and an OX40 transgenic T cell. Scale bar, 5 M.
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Figure 2. Differential Expression of Costimulatory Molecules on CD4CD3 Cells
(A) CD4 and CD11c cells were isolated from Rag1 mice and then incubated overnight at 37C before immunostaining with the indicated
antibodies. Results are representative of more than 30 experiments.
(B) Relative levels of mRNA TNF ligands in FACS-sorted populations of CD4CD3 cells and DCs. CD4 and CD11c cells were FACS sorted
from Rag1 mice. Isolated populations were 95% pure. Results are representative of two separate experiments.
(C) CD4 cells were isolated from Rag1 mice and costained with CD4 and B220. Gated CD4 cells were then stained for B220 and either
CD30 ligand or OX40 ligand. Results are representative of three experiments.
ligand after activation through CD40 (Brocker et al., ble explanations for this: (1) TNF ligands are known to
be cleaved readily by metalloproteases (Crowe et al.,1999; Ohshima et al., 1997), CD4CD3 cells do not
require additional activation beyond simply being put in 1995), and this could have occurred during the purifica-
tion process in vitro, or (2) the CD4CD3 cells mightculture for 12 hr.
only upregulate these molecules after in vitro culture. To
differentiate between these two possibilities, we FACSFreshly Isolated CD4CD3 Cells Express High Levels
sorted freshly isolated CD4CD3 cells and CD11c DCof mRNA for OX40 Ligand and CD30 Ligand
subsets. mRNA was made from sorted populationsFreshly isolated CD4CD3 cells do not express detect-
able OX40 ligand or CD30 ligand. There were two possi- which were 95% pure, and RNA message for TNF
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Table 1. Phenotypic Characterization of CD4CD3 Cells
Surface Antigen CD4CD3 Cells Mebius et al., 1997
CD4  
MHC class II  
CD25 (IL-2R)  
CD132 (IL-2Rc)  
CD44  
Thy1.2 (CD90.2)  
CD3  
CD11c  
CD40  
CD80  
CD86  
B220  
NK1.1  
L-selectin (CD62L) / 
CD28  n.d.
B220  
CXCR5  mRNA
Pan-NK DX5 mAb  n.d.
CD8  n.d.
CD45  
Macrophage F4/80  n.d.
MARCO  n.d.
Figure 3. Comparison of the Effects of Flt3 Ligand and Cytokines
ligands was quantified using PCR. After correction for that Signal through the Common Receptor  Chain on CD4CD3
Cells and Dendritic Cells	-actin levels, CD4CD3 cells expressed 100-fold
Differential effects of (A) Flt3 ligand (results are representative ofgreater OX40 ligand mRNA than CD11c DCs and 50-
three experiments) and (B) common cytokine receptor  chain (re-fold excess of CD30 ligand mRNA (Figure 2B). This is
sults are representative of two experiments) on the development ofdirect evidence that CD4CD3 cells synthesize OX40
CD11c DCs and CD4CD3 cells.ligand and CD30 ligand mRNA in vivo.
CD4CD3 Cells Resemble a Population Described to
Neonatal CD4CD3 cells (Mebius et al., 1997) ex-Colonize Neonatal Lymph Nodes but Are Distinct
press CD132 (the common cytokine receptor  [] chainfrom CD4CD3B220 Plasmacytoid Cells
for the cytokines IL-2, IL-4, IL-7, IL-9, and IL-15), andThe population of CD4CD3 cells that we isolated from
IL-7 receptor-deficient mice have fewer CD4CD3 cellsRag1 spleens was phenotypically very similar to a pop-
(Adachi et al., 1998). To test whether the CD4CD3ulation characterized in neonatal lymph nodes (Mebius
cells that we found in adult mice were dependent onet al., 1997) (see Table 1). They express CD45 but not
CD132 signals, we compared spleens of Rag1 micemacrophage, B, or T cell markers. They were also distin-
sufficient or deficient in CD132. Although the spleensguished from CD4CD3 B220CD11clow murine plas-
of CD132 Rag1 mice were smaller than those frommacytoid cells that secrete large quantities of type I
CD132 Rag1 mice, this translated into a 2.4-fold re-interferons in response to viral stimuli (Asselin-Paturel
duction in the numbers of CD8CD11c DCs and a 2.8-et al., 2001; Nakano et al., 2001). Whereas our cells were
fold reduction in CD8CD11c DCs. In contrast, thestrongly positive for OX40 ligand and CD30 ligand, the
number of CD4CD3 cells isolated from each spleenCD4CD3 B220CD11clow fraction was negative for
was reduced 6-fold in CD132 Rag1 mice (Figure 3B).these ligands (Figure 2C).
Unlike CD11c DCs, CD4CD3 Cells Are OX40 and CD30 Are Preferentially Expressed
on Th2 CD4 T CellsNot Expanded by Flt3 Ligand but Are
Dependent on CD132 The expression of CD30 ligand and OX40 ligand on
CD4CD3 cells suggested that they would preferen-The marked phenotypic differences between CD4
CD3 cells and conventional CD11c DCs suggested tially interact with OX40 and CD30 T cells. We first
differentiated OVA-specific transgenic CD4 T cells (OTII)that they might be derived from different cell lineages.
To investigate this further, we examined the in vivo re- under nonpolarizing Th0 and polarizing Th1 and Th2
conditions (Figure 4A). Th0, Th1, and Th2 primed cellssponse to the fms-like tyrosine kinase receptor 3 ligand
(Flt3 ligand), which has been reported to expand murine all expressed OX40 although expression was greatest
on Th2 cells. Th0 and Th1 cells expressed little CD30,CD11c DCs (Pulendran et al., 1997). All CD11c DC
subsets were increased 10-fold in Flt3 ligand-treated which in contrast was strongly expressed on Th2 cells.
Using allotypic markers to distinguish OX40 and OX40mice compared with PBS-injected controls (Figure 3A).
However, Flt3 ligand had little or no effect on the total transgenic CD4 T cells, we found that expression of
CD30 on Th2 cells did not depend on OX40. Experimentsnumbers of CD4CD3 cells/spleen, showing the
CD4CD3 population to be unresponsive to Flt3 ligand with OX40 and OX40 T cells cultured alone gave iden-
tical results (data not shown).as a growth factor.
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Figure 4. Expression of OX40 and CD30 on Th1 versus Th2 Cells, and Effects on Their Survival after Culture In Vitro with CD4CD3 Cells
(A) Expression of OX40, CD30, and intracellular cytokines in vitro on day 6 for (a) Th1, (b) Th0, and (c) Th2 cells. Cultures shown were mixtures
of OX40 (red) and OX40 (blue) splenocytes (initial ratio 0.9:1). Results are representative of ten separate experiments.
(B) OX40 and OX40 T cells were cultured under Th1 and Th2 conditions alone ( CD4CD3 ) or supplemented with 5  104 CD4CD3
cells ( CD4CD3 ). Data show FSC and annexin V staining on OX40 T cells (blue) and OX40 T cells (red). Results are representative of
three experiments.
(C) Ratio of OX40/OX40 (initial ratio 1:1) T cells at different days of culture with and without supplemented CD4CD3 cells (data from [B]).
In initial cultures, the ratio of OX40 to OX40 CD4 ture with a fluorescent dye showed this to be attributable
to increased proliferation of OX40 T cells (data notT cells was 1:1 (1:0.9 in the experiment shown). After
6 days in culture in vitro, OX40 CD4 T cells outnum- shown). In contrast, OX40 Th2 CD4 cells outnumbered
OX40 cells by a small margin (1:0.7).bered their normal counterparts under Th0 (5.5:1) and
Th1 conditions (2.5:1), and labeling of cells prior to cul- Deficiency of OX40 did not affect the capacity of exog-
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enously provided IL-4 to induce Th2 (IL-4 and IL-10) CD4 cells were located revealed that 53/173 (31%)
were associated with CD4CD3 cells (Figure 1F). Ofor exogenously provided IL-12 to induce Th1 (IFN-)
these cells the great majority (50/80 [63%]) were asso-cytokines, although OX40 Th2 IL-4-producing cells
ciated with CD4CD3 cells in the outer T zone and Boutnumbered OX40 cells by 2.6:1, whereas the reverse
cell areas. Of the 93 OX40 cells remaining in the inner Twas true for IFN--expressing cells where OX40 CD4
zone, only three (3%) were associated with CD4CD3cells outnumbered OX40 cells by 2.2:1.
cells. By comparing the ratio of OX40 to OX40 T cells
in B and T cell areas (Figure 5C), it is also clear that theTh2 but Not Th1 Cells Preferentially Survive When
increased survival of OX40 cells is associated with theirCocultured with CD4CD3 Cells
location in B follicles (median OX40/OX40 ratio 12.08)To investigate directly the effects of CD4CD3 cells
and the outer T zone (median OX40/OX40 ratio 4.02).on T cells, we primed OX40 and OX40 OTII cells (initial
In contrast, their survival in the inner T zone is relativelyratio 1:1) under Th1 and Th2 conditions in the presence
independent of OX40 signals (median OX40/OX40 ra-and absence of CD4CD3 cells (Figure 4B). As in previ-
tio 1.36).ous experiments, under Th1 conditions, OX40 OTII
cells outnumbered their OX40 counterparts by 2:1,
OX40 Signals Are Critical for Sustaining T Cell Memoryand this was not changed by adding CD4CD3 cells
for Secondary Antibody Responses(Figure 4B). However, on day 6 T cells cultured with
The above data showed direct interactions betweenCD4CD3 cells did show a slight reduction in forward
CD4CD3 cells and OX40 CD4 T cells at the B:T inter-scatter (FSC), and this was independent of OX40 signals.
face and in B follicles, and this was correlated withThis reduction in FSC was more marked on Th2 cells,
the preferential accumulation of OX40 cells at thesebut again this was independent of signaling through
locations. To test whether OX40 signals to T cells wereOX40. However, the survival of OX40 Th2 cells but
required to maintain T help for B cells, we investigatednot Th1 cells was clearly augmented by coculture with
antibody production to protein antigens in mice suffi-CD4CD3 cells (Figures 4B and 4C). The reason for the
cient and deficient in OX40 (Figure 6). There was littlepreferential survival of OX40 Th2 cells with CD4CD3
difference in the primary IgM and IgG antibody re-cells was attributable to decreased annexin-positive
sponses in the two groups of mice (Figure 6Aa), butapoptotic cells in this population (26% versus 43%).
after boosting (Figures 6Ab and 6Ac), median IgG- andIn contrast, the percentage of annexin-positive cells in
IgM-specific antibody titers were reduced in OX40-defi-OX40 and OX40 Th1 cells was similar (29% versus
cient mice.30%) (Figure 4B).
We reasoned that if OX40 signals from CD4CD3
cells were important in keeping memory T cells alive,OX40 CD4 Cells Associate with CD4CD3
OX40-deficient mice would have an impaired capacityCells In Vivo
to provide T cell help to a new B cell determinant onOX40 CD4 T cells form a minor fraction of the total
the carrier protein. To test this, we analyzed the capacityCD4 cell pool in normal mice (in our hands approximately
of mice primed with a carrier protein to provide help5%). To identify the cellular associations of these OX40
to NP-specific B cells following immunization with NP
CD4 cells, we developed techniques to stain for OX40 by
conjugated to the carrier protein. Again, both IgG and
confocal microscopy, using tissue sections from OX40
IgM anti-NP responses were impaired in OX40-deficient
mice to confirm specificity of staining (data not shown).
mice compared to controls (Figure 6B).
Figure 1E shows a low-power and the inset shows a These data pointed to defective T cell memory for B
high-power image of an OX40 CD4 cell interacting with cell help. To pinpoint further the defect in OX40-deficient
a CD4CD3 cell. In separate experiments, we found mice, we exploited a system in which we can measure
17% and 29% of OX40 CD4 cells to have membrane the capacity of a cohort of memory T cells to provide
associations with CD4CD3 cells. This demonstration help for secondary antibody responses. We use mice
of the physical association of CD4CD3 cells and deficient in CD28 signaling by virtue of transgenic ex-
OX40 CD4 cells is proof of the opportunity for OX40 pression of CTLA-4Ig (CTLA-4Ig) (Lane et al., 1994).
signaling between them. Injection of an agonistic CD28 mAb into CTLA-4Ig mice
To visualize the functional relevance of intact OX40 transiently reverses CD28 blockade and generates a
signals to primed transgenic CD4 T cells, we transferred cohort of CXCR-5 CD4 T cells, which induce GCs and
allotype marked OX40and OX40 transgenic OVA-spe- the production of high-affinity IgG antibodies (Walker et
cific T cells into Rag1 recipients and compared their al., 1999). Clearance of the CD28 mAb (via a mouse anti-
survival after immunization with the Th2 antigen, alum- hamster CD28 mAb antibody response) restores CD28
precipitated OVA (Figure 5A). Following immunization, blockade and effectively blocks the recruitment of new
there was rapid expansion of both OX40 and OX40 T cells into antibody responses, as naive T cells are
transgenic T cells, and the majority of transferred T cells dependent on CD28 signaling (Lane et al., 1994). Com-
downregulated expression of CD62L (L-selectin). Ini- parison of the effects caused by injecting CD28 mAb into
tially, survival was not OX40 dependent, but after a week OX40-deficient or -sufficient CTLA-4Ig mice provides a
there was preferential survival of OX40 cells; after 4 direct readout of the contribution of OX40 signals to
weeks they outnumbered their negative counterparts by T cell memory for antibody production (Figure 6C). There
3:1 (Figure 5B). This preferential survival was associated was little difference in primary (day 7) IgM and IgG anti-
with stable expression of OX40 on40% of CD4 T cells body responses in the two groups of mice. However,
(Figure 5A), a much higher proportion than in normal sustained IgG antibody production (day 46) was mark-
mice, reflecting the fact that virtually all CD4 cells are edly impaired in CTLA-4Ig mice deficient in OX40 sig-
naling.activated in this model. Analysis of where these OX40
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Figure 5. OX40-Dependent CD4 T Cell Sur-
vival In Vivo Is Associated with Accumulation
in the Outer T Zone and B Follicles
Splenocytes from OX40 (gated CD4 cells
in red) and OX40 (gated CD4 cells in blue)
OTII mice were mixed to give a final ratio of
0.9:1 and were transferred i.p. into Rag1
mice which were immunized 24 hr later with
alum-precipitated OVA. Results are represen-
tative of three separate experiments.
(A) Levels of CD62L before and after immuni-
zation at the times indicated. Also shown is
staining for OX40 on the OX40 (blue) and
OX40 (red) CD4 T cell populations.
(B) The relative survival advantage of OX40
compared with OX40 CD4 T cells at the indi-
cated days after immunization.
(C) The ratio of OX40/OX40 T cells in the
follicle (B), outer T zone (B/T), and inner T
zone (T) on day 21. The results are pooled
data from three mice.
The conclusion that OX40 signals are required to sus- (Pulendran et al., 1997), our CD4CD3 cells were not
expanded by Flt3 ligand, nor were we ever able to dem-tain T cell memory for long-term antibody production
onstrate antigen presentation to naive T cells (data notwas independently verified by transferring either OX40
shown). They were also clearly different from the re-or OX40 transgenic T cells into Rag1 recipients and
cently described B220 population of CD4CD11clowtesting whether they could provide help for IgG re-
CD3 plasmacytoid cells that secrete large quantitiessponses following immunization with NP-ovalbumin
of type I interferons in responses to viral stimuli (Asselin-(Figure 6D). As in the above experiment, mice that re-
Paturel et al., 2001; Nakano et al., 2001) and which areceived OX40 T cells showed a marked deficiency in
expanded by Flt3 ligand (Gilliet et al., 2002).their capacity to sustain IgG antibody responses.
Isolated CD4CD3 cells expressed little CD80 or
CD86, costimulatory molecules expressed by DCs, but
Discussion they did express high levels of the TNF ligands, OX40
ligand, and CD30 ligand, although not 4-1BB ligand and
In this paper, we have characterized an accessory cell CD27 ligand, after in vitro culture. Freshly isolated cells
that interacts with antigen-specific CD4 T cells after expressed high levels of mRNA encoding these proteins,
priming on DCs and continues to be associated with indicating that they had the potential to express these
memory T cells 4 weeks after priming. These CD4CD3 proteins in vivo. It has been reported that primed Th2
accessory cells are distinct from conventional CD11c cells preferentially migrate to sites where CD4CD3
DCs known to present antigen to CD4 T cells in the T cells are located (Randolph et al., 1999) suggesting that
zone and are specifically located at sites of T:B collabo- they might receive signals from this cell type. In support
ration: at the B:T interface and in B follicles. Their local- of this, we found CD30 and OX40 were preferentially
ization was not dependent on immunization or on intact expressed on Th2 cells cultured in vitro and found that
signaling through CD28 and OX40. We also found them survival of Th2 but not Th1 cells was substantially aug-
in Rag1 mice, suggesting that their presence was not mented by OX40 signals from CD4CD3 cells.
dependent on lymphocytes. Our in vitro data was further supported by our obser-
Phenotypically, the CD4CD3 cells that we isolated vations that OX40-expressing T cells primed by a Th2
closely resembled those identified in neonatal mice immunogen remain strongly associated with CD4CD3
(Mebius et al., 1997). These cells affect the recruitment cells in the outer T zone and B cell areas 4 weeks after
and organization of lymphoid cells in lymph nodes and priming and that the preferential survival of CD4 cells
Peyer’s patches by virtue of expression of lymphotoxin that could signal through OX40 (Chen et al., 1999; Kopf
et al., 1999; Murata et al., 2000; Rogers et al., 2001)1	2 (Futterer et al., 1998). Unlike conventional DCs
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Figure 6. OX40 Dependence of T Cell Help
for Sustained IgG Antibody Responses
Antibody titers in mice sufficient () and defi-
cient () in OX40 signaling. Groups of mice
were immunized and boosted on the days
indicated, and titers of IgG and IgM antibod-
ies were measured.
(A) Groups of mice were primed and boosted
with CG, and boosted twice further with NP-
CG. Antibody titers shown are to the carrier
protein, CG. Results are representative of
two experiments.
(B) As above, except titers shown are against
the hapten, NP.
(C) Groups of mice transgenic for CTLA-4Ig
were immunized with NP-CG together with
100 g anti-CD28 mAb. Mice were bled on
day 7 and subsequently boosted with NP-
CG on days 14, 28, and 41. Five days after
final boost (day 46), mice were rebled. Shown
are day 7 primary IgM and IgG anti-NP anti-
body titers and day 46 quartenary IgM and
IgG anti-NP antibody titers. Results are repre-
sentative of three separate experiments.
(D) OX40 or OX40 splenocytes from OTII
mice were transferred into Rag1 recipients
and subsequently immunized as indicated.
Shown are IgM and IgG anti-NP titers at the
indicated time points. Results are representa-
tive of two separate experiments.
occurred where CD4CD3 cells were located, in the T cells in the inner T zone where OX40 ligand-expressing
CD11c cells have been found (Malmstrom et al., 2001).outer T zone and B follicles.
We did find significant numbers of OX40-expressing However, in our studies we found that the survival of
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AL), developed with p-nitrophenylphosphate substrate (KPL, Gaith-primed CD4 cells in the central T zone was essentially
ersburg, MA). The absorbance was read at 405 nm.OX40 independent.
The role of CD30 ligand expressed by CD4CD3 cells
Antibodies for Stainingis currently unknown, but it is possible that there is a
Anti-CD4 PE, anti-CD45.1 FITC, and anti-B220 FITC mAbs and bio-
level of redundancy between OX40 and CD30. We found tinylated mAbs against CD11c, mouse I-Ab, CD80, CD86, CD132,
that the reduction in FSC in Th2 cells cultured with OX40, OX40 ligand, CD30, CD30 ligand, CD62L, IFN-, IL-4, and IL-
CD4CD3 cells did not depend on OX40 signals. How- 10 were purchased from Pharmingen (Oxford). Anti-CD8 FITC mAb
and anti-CD8 PE mAb were obtained from CALTAG laboratoriesever, as CD30 expression is normal on OX40-deficient
(Burlingame, CA). Biotinylated anti-CD40 mAb was a kind gift of Dr.Th2 cells, it is possible that signaling through CD30 is
Ton Rolink (Basel Institute for Immunology), and the fusion proteinsresponsible for the decrease in FSC. This is currently
mCTLA4Ig and mOX40Ig were made as described elsewhere
under investigation. (Brocker et al., 1999; Lane et al., 1994). The macrophage markers
In summary, we propose an additional role for the F4/80 and MARCO (macrophage receptor with collagenous struc-
CD4CD3 cells already shown to support the organiza- ture) were obtained from Serotec (Oxford).
As the second-step staining reagents, streptavidin FITC andtion of lymphoid tissue. We suggest that primed CD4
streptavidin PE were purchased from DAKO (High Wycombe, UnitedT cells migrate to CD4CD3 cells where they receive
Kingdom), and streptavidin cychrome was purchased from Phar-OX40 and CD30 signals. This interaction could be a
mingen. Goat anti-human IgG FITC was obtained from Southern
checkpoint to ensure that T cells are fully committed to Biotechnology Associates for the second-step antibody in conjunc-
the provision of B cell help. In addition we suggest that tion with the fusion proteins.
these cells provide OX40 survival signals to memory
T cells when antigen is scarce, so that they are subse- Immunohistology for Confocal Microscopy
Spleens from normal and injected mice were snap frozen in liquidquently available for secondary responses.
nitrogen and stored in sealed polythene bags at 70C until use.
Five micrometer cryostat sections of the spleens were mounted onExperimental Procedures
four-spot glass slides for immunohistology and confocal mi-
croscopy.Mice
Sections to be examined by confocal microscopy were stainedNormal, CD40 ligand-deficient and Rag1-deficient (Rag1) C57Bl/6
with fluorochrome-conjugated antibodies diluted in PBS containingmice were bred and maintained in our animal facility. OX40-deficient
1% bovine serum albumin. Slides were preblocked with 10% goatmice (Kopf et al., 1999) were crossed with the ovalbumin (OVA)-
serum, and anti-rat and anti-hamster second-step reagents werespecific TCR transgenic (OT-II) mice (Barnden et al., 1998) and were
preabsorbed with normal mouse serum. Armenian hamster anti-homozygous for the expression of CD45.2. Homozygous OT-II mice
CD3, hamster anti-CD11c, rat anti-CD4, and rat anti-CD8 were pur-were also crossed with CD45.1 congenic C57Bl/6 mice to obtain
chased from Pharmingen. Goat anti-rat TRITC was purchased fromallotype-marked OVA-specific transgenic T cells that could be dis-
Southern Biotechnology Associates, and goat anti-Armenian ham-tinguished in cultures from OX40-deficient CD45.2 OTII cells. OX40-
ster Cy5 and goat anti-mouse IgM AMCA were purchased fromdeficient mice (Kopf et al., 1999) were crossed with the CTLA-4Ig
Jackson Laboratories Inc. (via Stratech).transgenic (CTLA-4Ig) mice. OX40-deficient and -sufficient CTLA-
To stain OX40 CD4 T cells, we used biotinylated anti-OX40 mAb4Ig mice were obtained from the F1 intercross. All mice were used
(Pharmingen), followed by goat anti-biotin FITC (Vector Labs, CA).between 6 and 16 weeks of age and were sex and age matched as
This signal was further amplified using rabbit anti-FITC and goatfar as possible in individual experiments. All mice were housed and
anti-rabbit FITC third and fourth stages. Stained sections weremaintained in the University of Birmingham, Biomedical Services
mounted with DABCO in glycerol at pH 7 and examined by confocalUnit. The spleens from the CD132 Rag1 and CD132 Rag1 mice
microscopy.were provided by Dr. B. Stockinger (Mill Hill).
Image Acquisition and Analysis of Confocal Images
Cell Transfer and Immunization Confocal images were acquired using a Zeiss LSM510 laser scan-
107 splenocytes (1–2  106 CD4 T cells) from CD45.1 OTII mice ning confocal head with a Zeiss Axiovert 100M microscope. Digital
were injected i.p. into congenic CD40 ligand-deficient CD45.2 recipi- images were recorded in four separately scanned channels with no
ents. Twenty-four hours after cell transfer they were immunized i.p. overlap in detection of emissions from the respective fluorochromes.
with either 200g ovalbumin (OVA) (Sigma, Dorset, United Kingdom) FITC-conjugated antibodies were excited with the 488 nm line of
or NP-OVA precipitated in a commercial alum-containing gel, Alu- the argon laser, and emissions were collected in a channel defined
Gel-S (SERVA, Heidelberg, Germany). Similar transfers were per- by a 505–550 nm bandpass filter. TRITC antibodies were excited
formed using Rag1 mice as recipients and/or by injecting mixtures with a 543 nm helium laser, and emissions were collected in a
of OX40 and OX40 splenocytes. channel defined by a 560–615 nm bandpass filter. Cy5-conjugated
For other immunizations, mice were immunized with either 100 antibodies were excited with the 633 nM helium laser, and emissions
g chicken -globulin (CG) (Jackson Immunoresearch via Stratech, were collected using a 650 nm longpass filter. Finally, AMCA-conju-
Luton, Bedfordshire, United Kingdom) or 100 g NP-CG i.p. For gated antibodies were excited with an Enterprise ultraviolet laser
priming, proteins were precipitated with Alu-Gel-S as above. Boosts with 351 and 364 nm excitation lines, and emissions were collected
were with soluble protein dissolved in PBS (pH 7.4). in a channel defined by a 385–470 nm bandpass filter.
CTLA-4Ig mice deficient or sufficient for OX40 were immunized To identify positively cells that expressed CD4 but lacked CD3 or
as above except that 100 g of anti-CD28 mAb was included with CD11c (CD4CD3 CD11c cells), sections were stained with goat
the priming protein (clone 37.51, a kind gift of Dr. Jim Allison, Berke- anti-mouse IgM AMCA, rat anti-mouse CD4 identified with goat anti-
ley, CA). Boosts were with antigen alone, and no additional anti- rat TRITC, and the hamster antibodies to CD11c and CD3 identified
CD28 mAb was given. with goat anti-hamster Cy5. Staining for CD3 and CD11c mAbs was
optimized individually.
Images were processed using the Zeiss LSM510 software, whichELISA
Plates were coated with 5 g/ml NP-bovine serum albumin or 10 allows pixel by pixel manipulation of channels within an image. The
Zeiss confocal software stores a standard 8 bit (pixel intensitiesg/ml CG diluted in 0.05 M carbonate buffer (pH 9.6). Serum sam-
ples were titrated on ELISA plates blocked with 1% bovine serum range from 0–255) array of 1024  1024 pixels for each channel
recorded. To identify positively cells that expressed CD4 but notalbumin in PBS (pH 7.4). Bound IgG and IgM were detected using
alkaline phosphatase-conjugated goat anti-mouse IgG and goat CD3 or CD11c, the matrix containing values for CD3 and CD11c
was divided into the matrix containing values for CD4. In the resultinganti-mouse IgM (Southern Biotechnology Associates, Birmingham,
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matrix, pixels carrying only CD4 remain positive, and pixels coex- CD30 Ligand
Forward primer, 5
(AGGATCTCTTCTGTACCCTGAAAAGTA); re-pressing significant levels of CD3 or CD11c are reduced to back-
ground levels. verse primer, 5
(GTTTGGTATTGTTGAGATGCTTTGA); FAM probe,
5
(CAAGAAGTCATGGGCCTACCTCCAAGTG).For positive identification of CD11c cells, sections were stained
with goat anti-mouse IgM AMCA, and the hamster antibodies to 4-1BB Ligand
Forward primer, 5
(GGCCGCCTGCACTGAA); reverse primer, 5
(CAGCD11c identified with goat anti-hamster Cy5.
In experiments involving the transfer of mixed OX40 and OX40 AAGCAGCAAAACCAAAGC); FAM probe, 5
(TCTGTTCCCGCCACC-
CAAAGCTCT).lymphocytes, OX40 cells in spleen sections were positively identi-
fied by staining for the congenic CD45.1 marker, CD4 and CD3. CD27 Ligand
Forward primer, 5
(CACGGAGATGTCCTCTGTACCA); reverse pri-OX40 T cells were those CD4CD3 cells not staining for CD45.1.
B cell areas were defined by staining with IgM (B). The outer T zone mer, 5
(TGAACTCCAAAGAAGGTCTCATCA); FAM probe, 5
(CCTCT
GCTGCCGTCCCGCA).(B:T) was defined as an approximately two cell-wide area at the T
zone border. The inner T zone was the remaining T cell area (T).
More than 200 OX40 and OX40 T cells were counted from at least Flt3 Ligand Treatment
three regions of randomly selected white pulp from each of three Rag1 mice were injected i.p. with recombinant human Flt3 ligand
mice. (a kind gift from the Immunex Corporation, Seattle, WA). Flt3 ligand
or PBS was injected on days 0, 2, 4, and 7. Mice were sacrificed on
day 8, and suspensions of spleen cells were prepared as describedPreparation of CD4CD3 Cells
above. A total of 106 cells were stained with anti-CD4 PE, anti-CD8and DCs Enriched Populations for FACS Staining
FITC, and biotinylated anti-CD11c and streptavidin cychrome. Theand FACS Cell Sorting
numbers of each cell subset isolated/spleen were calculated byCell suspensions were made from the spleens of Rag1 and common
measuring by FACS staining the proportion of CD4CD11c,cytokine receptor  chain deficient Rag1 mice as follows. Spleens
CD8CD11c, and CD8CD11c cells, and multiplying this percent-were cut into small (8 mm3 ) fragments and then cultured in serum-
age by the total numbers of viable cells obtained from each spleen.free RPMI with collagenase D (1 mg/ml) (Boehringer Mannheim) for
45 min at 37C. Digested fragments were crushed between gauze.
T Cell Stimulation and Intracellular Cytokine StainingAfter depletion of red blood cells with Gey’s solution, the cell sus-
For Th0, Th1, and Th2 polarized cell cultures, splenocytes werepensions were pooled and resuspended in MACS buffer containing
collected from OX40-sufficient (CD45.1) and -deficient (CD45.2) OT-10% mouse serum as per the manufacturer’s instructions. CD11c
II mice. OX40 and OX40 cells were mixed 1:1 (total 2  106 cells/cells were enriched by incubating the cell suspension with MACS
ml/well), and the final ratio of CD4 T cells was determined by flowanti-mouse CD11c microbeads (Miltenyi Biotec Ltd., Surrey, United
cytometry. Mixtures were incubated in RPMI 1640 medium con-Kingdom) at 100 l/108 cells for 15 min at 4C. CD11c bead-
taining L-glutamine (GIBCO BRL), and 10% FCS (GIBCO BRL) withattached single cells were positively selected using a midiMACS
1 M/ml ovalbumin 323-339 peptide at 37C (Th0 conditions). Forseparation unit according to the manufacturer’s protocol. CD4 cells
Th1 conditions, 10 ng/ml IL-12 (Peprotech EC, Ltd., London) andfrom CD11c cells were enriched as above except that anti-CD4
10 g/ml anti-IL-4 mAb were added to cultures, and for Th2 condi-coated microbeads were used (Miltenyi Biotec Ltd.). The resulting
tions, 10 ng/ml IL-4 (Peprotech EC, Ltd.) and 10 g/ml anti-IL-12populations were stained after overnight culture at 37C with appro-
mAb were added. All cells were cultured for 6 days and then stainedpriate antibodies and analyzed by flow cytometry using a FACScan
to detect the surface expression of OX40 and CD30. For intracellular(Becton Dickinson, Mountain View, CA).
cytokine staining, cultures were restimulated for 4 hr at 37C inPurified CD4CD3 cells and DC subpopulations were prepared
the presence of GolgiStop (following the manufacturer’s protocol,by cell sorting using a FACSVantage (Becton Dickinson): (1)
Cytofix/Cytoperm Plus cytostain kit, Pharmingen) on anti-CD3CD4CD11c, (2) CD8CD11c, and (3) CD8CD11c populations.
coated plates (coated overnight with 5 g/ml anti-CD3 mAb at 4C).Purified populations were 95% pure.
After restimulation, the cells were surface stained for CD4 and
CD45.1, and then fixed and permeabilized according to the manu-Semiquantitative RT-PCR
facturer’s protocol for the cytokine kit. The cells were then stainedTotal RNA was prepared from FACS-sorted cell subsets using RNA-
optimally with mAbs (listed above) to detect intracellular IL-4, IL-zol B according to the manufacturer’s instructions (Biogenesis,
10, and IFN-.Poole, United Kingdom). cDNA enriched for mRNA precursors was
prepared using avian reverse transcriptase (Life Technologies, Pais-
Annexin V Stainingley, United Kingdom) and oligo dT primers (Amersham Pharmacia
Surface molecules were optimally stained with CD45.1 FITC andBiotech, Buckinghamshire, United Kingdom). cDNA was diluted to
CD4 CyChrome. The cells were washed twice with cold PBS, resus-a final volume of 100 l. Gene expression was quantified using
pended in binding buffer (Pharmingen) at a concentration of 106the ABI Prism 7700 sequence detection system (PE Biosystems,
cells/ml, and stained with an optimal amount of Annexin V PE (Phar-Warrington, United Kingdom). By amplifying TNF ligands and 	-actin
mingen) for 15 min at RT in the dark. Annexin V was detected byin the same PCR tube, variations in cDNA preparations were cor-
flow cytometry within 30 min of staining.rected for, so that levels of TNF ligands between cell subsets could
be compared directly. Signals from the specific probes conjugated
Acknowledgmentsto the dye VIC (for 	-actin) or FAM (6-carboxyfluorescein) (for TNF
ligands) were measured at the end of each of the 44 PCR cycles to
This work is funded by the Wellcome Trust. H.E.W. is supported bygenerate sigmoid plots for TNF ligands and 	-actin for each sample.
an endowment fund fellowship. We would like to thank ManfredA threshold was set on the exponential phase of the sigmoid plots,
Kopf for sending us the OX40-deficient mice and also Bill Heathand the cycle number (CT) at which each sample crossed this thresh-
and Frank Carbone for allowing us to obtain the OTII transgenicold was recorded. The relative concentration of TNF ligands in the
mice. Recombinant human Flt3 ligand was a kind gift of the Immunexsamples was compared by correcting for the 	-actin signals.
Corporation. Jim di Santo kindly gave permission to use the CD132The specific primers and probe sequences were synthesized by
mice, and Gitta Stockinger sent us spleens from Rag1 and Rag1PE Biosystems.
CD132 mice for our analysis. These experiments could not have-actin
been done without the expert help of the staff of the BirminghamForward primer, 5
(CGTGAAAAGATGACCCAGATCA); reverse
University animal facility (BMSU), particularly John Atkinson.primer, 5
(TGGTACGACCAGAGGCATACAG); VIC probe, 5
(TCAA
CACCCCAGCCATGTACGTAGCC).
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